{"disease":{"id":"active-systemic-juvenile-idiopathic-arthritis","name":"active systemic juvenile idiopathic arthritis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05925452","title":"To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.","phase":"NA","overall_status":"RECRUITING","enrollment_count":221,"lead_sponsor_name":"Changchun GeneScience Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT00570661","title":"Open Label, Multicentre Trial to Assess Safety and Efficacy of ITF2357 in Active Systemic Juvenile Idiopathic Arthritis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Italfarmaco","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}